Related Experiment Video
Updated: Jun 7, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Causal association between COVID-19 vaccination and thrombosis-related biomarkers/thrombosis/ischemic stroke:
Xiaoqi Peng1, Lianjia Zhuo2, Yong Ma3
1Department of Emergency, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine (Futian), Shenzhen, 518034, Guangdong Province, PR China.
Insights
This study used Mendelian randomization to investigate COVID-19 vaccination effects. Genetically predicted vaccination showed potential causal links to ischemic stroke and large artery stroke risks.
Area of Science:
- Genetics and Epidemiology
- Cardiovascular Research
- Infectious Disease Epidemiology
Background:
- Inconsistent findings exist regarding COVID-19 vaccination and thrombosis/ischemic stroke.
- Previous observational studies lack definitive causal evidence.
Purpose of the Study:
- To assess the causal relationship between COVID-19 vaccination and thrombosis biomarkers, thrombosis, and ischemic stroke.
- Utilizing Mendelian randomization (MR) to infer causality.
Main Methods:
- Two-sample MR analysis using publicly available genome-wide association study (GWAS) data.
- Inverse variance weighted (IVW) as the primary analysis method, with multiple sensitivity analyses.
- Assessed genetic associations with thrombosis biomarkers (CCL3, MCFD2) and stroke outcomes.
Main Results:
- Genetically predicted COVID-19 vaccination was associated with lower levels of CCL3 and MCFD2.
- Significant causal effects were found between COVID-19 vaccination and increased risk of ischemic stroke and large artery stroke (LAS).
- Sensitivity analyses confirmed the robustness of the findings, with no single SNP dominating the causal estimate.
Conclusions:
- Evidence suggests a potential causal association between COVID-19 vaccination and altered CCL3/MCFD2 levels.
- Findings indicate a possible causal link between COVID-19 vaccination and increased risk for ischemic stroke and LAS.
- Further research is needed to elucidate mechanisms and validate these preliminary findings in diverse populations.
Background:
Observational studies about the association between coronavirus disease 2019 (COVID-19) vaccination and thrombosis/ischemic stroke are inconsistent. The aim of this study is to assess the causality between COVID-19 vaccination and thrombosis-related biomarkers/thrombosis/ischemic stroke using mendelian randomization (MR) analysis.
Methods:
A two-sample MR analysis using publicly available genome-wide association study (GWAS) data was conducted. Causal effects were appraised using inverse variance weighted (IVW, as a primary method), with supplementary methods including constrained maximum likelihood and model averaging, MR-Robust Adjusted Profile Score, MR-Egger regression, simple mode, weighted median, and weighted mode. Sensitivity analyses were conducted using Cochran's Q test, MR-Egger intercept test, and leave-one-out analysis.
Results:
Genetically predicted COVID-19 vaccination was negatively associated with C-C motif chemokine 3 [CCL3, odds ratio (OR): 0.694, 95% confidence intervals (CI): 0.484-0.995] and multiple coagulation factor deficiency protein 2 (MCFD2, OR: 0.806, 95% CI: 0.675-0.963). Meanwhile, the IVW analysis revealed significant causal effects between genetically predicted COVID-19 vaccination and ischemic stroke (OR: 1.088, 95% CI: 1.006-1.177), large artery stroke (LAS, OR: 1.251, 95% CI: 1.028-1.521). The leave-one-out analysis revealed that no individual SNP exerted a significant effect on the overall causal estimate.
Conclusion:
Our study provided evidence supporting a potential causal association of genetically predicted COVID-19 vaccination with CCL3 levels, MCFD2 levels, ischemic stroke risk and LAS risk. These results provide preliminary evidence of potential adverse associations, but further studies are required to fully understand the mechanisms and to validate these findings across broader populations.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Causality in Epidemiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins

